Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) will hold its 4Q20 earnings conference call with the financial community on 23rd November 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at arrowheadpharma.com
Alternatively, callers may dial the number(s) 855-215-6159 Toll Free or 315-625-6887 Outside U.S., when prompted, enter passcode 8492751
Earnings Expectation
Arrowhead Pharmaceuticals, Inc. is reporting fourth quarter earnings results on Monday 23rd November 2020, after market close.
The consensus estimates from Thomson Reuters are income of $ 0.12 per share from $ 49.24 million in revenue. For the full year, analysts predict revenues of $ 129.53 million, while looking forward to loss of $ 0.21 per share.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The companys pipeline include ARO-AAT, a RNA interference (RNAi) therapeutic candidate for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3 to treat hypertriglyceridemia; ARO-ANG3 to reduce production of angiopoietin-like protein 3; ARO-ENaC to reduce production of the epithelial sodium channel alpha subunit in the airways of the lung; and ARO-HIF2 for the treatment of clear cell renal cell carcinoma.
